Novel Thiosemicarbazone Derivatives: In Vitro and In Silico Evaluation as Potential MAO-B Inhibitors
MAO-B inhibitors are frequently used in the treatment of neurodegenerative diseases such as Parkinson’s and Alzheimer’s. Due to the limited number of compounds available in this field, there is a need to develop new compounds. In the recent works, it was shown that various thiosemicarbazone derivati...
Guardado en:
Autores principales: | Derya Osmaniye, Berkant Kurban, Begüm Nurpelin Sağlık, Serkan Levent, Yusuf Özkay, Zafer Asım Kaplancıklı |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cfe17d4976e34513ab429bd9d92e62c3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antibacterial and antifungal activity of some thiosemicarbazones and 1,3,4-thiadiazolines
por: Brousse,Beatriz N., et al.
Publicado: (2004) -
Synthesis, Antiproliferative and Antimalarial Activities of Dinuclear Silver(I) Complexes with Triphenylphosphine and Thiosemicarbazones Ligands
por: Nur Adila Fatin Mohd Khir, et al.
Publicado: (2021) -
Synthesis and crystal structure of a solvated CoIII complex with 2-hydroxy-3-methoxybenzaldehyde thiosemicarbazone ligands
por: Julia A. Rusanova, et al.
Publicado: (2021) -
Dioxomolybdenum(VI) complexes of ONN chelating thiosemicarbazones: Crystallographic and spectroscopic (UV, IR and NMR) studies
por: Songül EĞLENCE BAKIR
Publicado: (2021) -
Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer’s Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis
por: Sumera Zaib, et al.
Publicado: (2021)